-+ 0.00%
-+ 0.00%
-+ 0.00%

Generic Sweden's (STO:GENI) Shareholders May Want To Dig Deeper Than Statutory Profit

Simply Wall St·11/20/2026 04:34:22
Listen to the news

The market shrugged off Generic Sweden AB (publ)'s (STO:GENI) solid earnings report. Our analysis showed that there are some concerning factors in the earnings that investors may be cautious of.

earnings-and-revenue-history
OM:GENI Earnings and Revenue History November 20th 2026

Examining Cashflow Against Generic Sweden's Earnings

In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. This ratio tells us how much of a company's profit is not backed by free cashflow.

That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future".

Over the twelve months to September 2026, Generic Sweden recorded an accrual ratio of 0.29. We can therefore deduce that its free cash flow fell well short of covering its statutory profit, suggesting we might want to think twice before putting a lot of weight on the latter. Indeed, in the last twelve months it reported free cash flow of kr28m, which is significantly less than its profit of kr32.2m. Generic Sweden's free cash flow actually declined over the last year, but it may bounce back next year, since free cash flow is often more volatile than accounting profits. The good news for shareholders is that Generic Sweden's accrual ratio was much better last year, so this year's poor reading might simply be a case of a short term mismatch between profit and FCF. Shareholders should look for improved cashflow relative to profit in the current year, if that is indeed the case.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Generic Sweden's Profit Performance

Generic Sweden's accrual ratio for the last twelve months signifies cash conversion is less than ideal, which is a negative when it comes to our view of its earnings. Because of this, we think that it may be that Generic Sweden's statutory profits are better than its underlying earnings power. Nonetheless, it's still worth noting that its earnings per share have grown at 40% over the last three years. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. Case in point: We've spotted 2 warning signs for Generic Sweden you should be mindful of and 1 of these is significant.

Today we've zoomed in on a single data point to better understand the nature of Generic Sweden's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.